Inflammation plays a pivotal role in cancer development and progression. Neutrophil-lymphocyte count ratio (NLR) is an indicator of systemic inflammatory response which is supposedly associated with gastric cancer (GC) development and progression. Since this parameter can be easily obtained from routine blood examination, it will be a great economic relief to gastric patients if we can bring it into clinical application.
OBJECTIVE:
The current study aims to evaluate the pretreatment NLR in gastric cancer patients through retrospectively reviewing the medical records.
METHODS:
A total of 327 patients hospitalized on a tertiary care hospital were retrospectively investigated and divided into two groups. Gastric cancer group were composed of patients with newly diagnosed, pathologically confirmed GC and the control group were patients with gastric polyp or benign gastric stromal tumor. The value of NLR in the presence and stage of gastric cancer was investigated in the entire gastric cancer group.
RESULTS:
Our study showed levels of NLR were significantly higher in gastric cancer cohort (2.17 (1.63-3.09) versus 1.62 (0.85-2.32), p< 0.001). After all the known confounders were excluded, NLR was an independent predicator of GC(OR = 1.446, 95%CI (1.121-1.866), and P= 0.005). Area under ROC curve (AUC) of NLR was 0.694. In addition, the results of Spearman's correlation showed NLR may have a positive correlation with size of tumor, N-stage, distant metastasis, and overall stage (r = 0.256, 0.256, 0.161 and 0.171, resp., all p < 0.05).
CONCLUSIONS:
The current study demonstrated that pre-treatment NLR may be a useful biomarker in the health care of gastric cancer patients.
AndersonR., TintingerG.R., FeldmanC., Inflammation and cancer: The role of the human neutrophil, S. Afr. J. Sci., 110 (2014) 36-41.
2.
ArdiV.C., KupriyanovaT.A., DeryuginaE.I., QuigleyJ.P., Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis, Proc. Natl. Acad. Sci. U.S.A., 104 (2007) 20262-20267.
3.
BalkwillF., MantovaniA., Inflammation and cancer: back to Virchow?The Lancet, 357 (2001) 539-545.
4.
ChenZ., XuW.R., QianH., ZhuW., BuX.F., WangS., YanY.M., MaoF., GuH.B., CaoH.L., XuX.J., Oct4, a novel marker for human gastric cancer, J Surg Oncol, 99 (2009) 414-419.
5.
ChungH.W., LimJ.B., Role of the tumor microenvironment in the pathogenesis of gastric carcinoma, World journal of gastroenterology: WJG, 20 (2014) 1667-1680.
6.
De LarcoJ.E., WuertzB.R., FurchtL.T., The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8, Clinical cancer research: an official journal of the American Association for Cancer Research, 10 (2004) 4895-4900.
7.
DengQ., HeB., LiuX., YueJ., YingH., PanY., SunH., ChenJ., WangF., GaoT., ZhangL., WangS., Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model, Journal of translational medicine, 13 (2015) 66.
8.
ErnstP., Review article: the role of inflammation in the pathogenesis of gastric cancer, Alimentary pharmacology & therapeutics, 13 Suppl 1 (1999) 13-18.
9.
FengJ.F., HuangY., ChenQ.X., Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma, World journal of surgical oncology, 12 (2014) 58.
10.
HirohisaK., YasuhikoK., MichiyoK., SongdeC., TsuyoshiK., MasanoriI., ShinjiT., YasukazuO., KazuakiC., Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma, Anticancer Research, 25 (2005).
11.
HundahlS.A., PhillipsJ.L., MenckH.R., The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the ``different disease'' hypothesis, Cancer, 88 (2000) 921-932.
12.
IlhanN., IlhanN., IlhanY., AkbulutH., KucuksuM., C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer, World J. Gastroenterol., 10 (2004) 1115-1120.
13.
KawaguchiM., AkagiM., GrayM.J., LiuW.B., FanF., EllisL.M., Regulation of vascular endothelial growth factor expression in human gastric cancer cells by interleukin-1 beta, Surgery, 136 (2004) 686-692.
14.
KilincalpS., CobanS., AkinciH., HamamciM., KaraahmetF., CoskunY., UstunY., SimsekZ., ErarslanE., YukselI., Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma, Eur. J. Cancer Prev., 24 (2015) 328-333.
15.
KimD.K., OhS.Y., KwonH.C., LeeS., KwonK.A., KimB.G., KimS.G., KimS.H., JangJ.S., KimM.C., KimK.H., HanJ.Y., KimH.J., Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer, BMC cancer, 9 (2009) 155.
16.
KohC.H., Bhoo-PathyN., NgK.L., JabirR.S., TanG.H., SeeM.H., JamarisS., TaibN.A., Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer, Br. J. Cancer, 113 (2015) 150-158.
17.
KubotaH., KotohT., MasunagaR., DharD.K., ShibakitaM., TachibanaM., KohnoH., NagasueN., Impact of screening survey of gastric cancer on clinicopathological features and survival: retrospective study at a single institution, Surgery, 128 (2000) 41-47.
18.
LeeK., HwangH., NamK.T., Immune response and the tumor microenvironment: How they communicate to regulate gastric cancer, Gut and liver, 8 (2014) 131-139.
19.
LimJ.B., ChungH.W., Serum ENA78/CXCL5, SDF-1/ CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer, Cytokine, 73 (2015) 16-22.
20.
LoureiroR.M., D'AmoreP.A., Transcriptional regulation of vascular endothelial growth factor in cancer, Cytokine & growth factor reviews, 16 (2005) 77-89.
21.
MüllerI., MunderM., KropfP., HänschG.M., Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?Trends in Immunology, 30 (2009) 522-530.
22.
MantovaniA., CassatellaM.A., CostantiniC., JaillonS., Neutrophils in the activation and regulation of innate and adaptive immunity, Nature reviews. Immunology, 11 (2011) 519-531.
23.
MilotE., FilepJ.G., Regulation of neutrophil survival/ apoptosis by Mcl-1, The Scientific World Journal, 11 (2011) 1948-1962.
24.
PosulE., YilmazB., AktasG., KurtM., Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?Wiener klinische Wochenschrift, 127 (2015) 262-265.
25.
RaczJ.M., CleghornM.C., JimenezM.C., AtenafuE.G., JacksonT.D., OkrainecA., RaghavanL.V., QuereshyF.A., Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors, Ann. Surg. Oncol., 22 (2015) 2343-2350.
26.
SmythM.J., DunnG.P., SchreiberR.D., Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity, Advances in immunology, 90 (2006) 1-50.
27.
SpolveratoG., MaqsoodH., KimY., MargonisG.A., LuoT., EjazA., PawlikT.M., Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratio in Patients After Resection for Hepato-Pancreatico-Biliary Malignancies, J. Surg. Oncol., 111 (2015) 868-874.
28.
TecchioC., ScapiniP., PizzoloG., CassatellaM.A., On the cytokines produced by human neutrophils in tumors, Seminars in cancer biology, 23 (2013) 159-170.
29.
UlichT.R., del CastilloJ., GuoK., SouzaL., The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation, The American journal of pathology, 134 (1989) 149-159.
30.
UlichT.R., del CastilloJ., GuoK.Z., In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs, Blood, 73 (1989) 108-110.
31.
UlichT.R., del CastilloJ., KeysM., GrangerG.A., NiR.X., Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes, Journal of immunology (Baltimore, Md.: 1950), 139 (1987) 3406-3415.
32.
WashingtonK., 7th Edition of the AJCC Cancer Staging Manual: Stomach, Ann. Surg. Oncol., 17 (2010) 3077-3079.
33.
Xin-JiZ., Yong-GangL., Xiao-JunS., Xiao-WuC., DongZ., Da-JianZ., The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis, International journal of surgery, 21 (2015) 84-91.
